Replies to post #202982 on Biotech Values

[dewophile]

makes sense they don't want to drive prices too low when introducing their next gen to the market
PS: they mentioned the VA pricing on a prior call

[jbog]

So then they are surrendering? Doesn't surprise me.

Merck just got approval for EU, is Abbvie packing their bags and going home?